Menu
Recruiting NCT06365710

Physiotherapy vs Telerehabilitation After Volar Plating of Distal Radius Fracture

No phase Interventional Orthopedic Procedures Physical Therapy Modalities Postoperative Care Rehabilitation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Telerehabilitation, Traditional physiotherapy.
Who it may be relevant to
Registry conditions: Orthopedic Procedures, Physical Therapy Modalities, Postoperative Care, Rehabilitation. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Finland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Randomized Controlled Trial Comparing Traditional Physiotherapy vs Telerehabilitation After Volar Plating of Distal Radius Fracture: a Study Protocol

Overview

Trial purpose is to research the outcome comparing traditional physiotherapy vs telerehabilitation after volar plating of distal radius fracture. Patients with distal radius fracture that meet the operative criteria set by the Finnish Current Care guidelines are randomized (1:1 computer generated sequence with random block size) to two parallel groups and will undergo operative treatment and traditional physiotherapy vs telerehabilitation. Baseline data is collected preoperatively and patients are followed at 1, 3 and 12 months after enrollment. The primary end-point is 3 months and the primary outcome is the Patient-Rated Wrist Evaluation (PRWE).

Interventions

  • Other Telerehabilitation
    Telerehabilitation program
  • Other Traditional physiotherapy
    Guided rehabilitation program with physiotherapist appointments

Primary outcome measures

  • Patient-Rated Wrist Evaluation (PRWE) [Time frame: 12 months]
Secondary outcome measures (8)
  • Grip strength [Time frame: 12 months]
  • Quick Disabilities of the arm, shoulder, and hand [Time frame: 12 months]
  • Pain (Visual Analogue Scale) [Time frame: 12 months]
  • Wrist range of motion (ROM) [Time frame: 12 months]
  • Adverse events [Time frame: 12 months]
  • Global improvement [Time frame: 12 months]
  • Patient-rated Quality of Life (EQ-5D) [Time frame: 12 months]
  • Cost-utility analysis [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

  • Distal radius fracture, which applies the surgical requirements
  • age between 18 to 65 years
  • Non concomitant injuries including ligament injuries and distal ulna fractures, however ulnar styloid avulsion is accepted
  • No significant comorbidities
  • No previous problems with the examined hand
  • Ability to understand Finnish fluently

Exclusion criteria

  • High energy or multiple injuries
  • Open fractures
  • Injury of both upper extremities
  • Other operative injury on the same side
  • Rheumatoid arthritis of other inflammatory joint disease
  • Heavy smoker (over 20 cigarettes per day)
  • Disease of medication slowing ossification
  • Alcohol or drug abuse
  • Psychiatric disorder with poor treatment balance
  • Neurological disorder which affects the function of the injured extremity
  • Fixation material other than a volar locking plate
  • Fracture fixation is not stable enough to start rehabilitation after 14 days

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Finland · 1 center
  • Division of Musculosceletal and Plastic Surgery, Hand Surgery Unit, Helsinki University Ho — Helsinki

Identifiers

NCT: NCT06365710 · HUS/206/2022

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗